Celldex Therapeutics shares owned by Point72 Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Point72 Asset Management
from 13F filings
Historical chart of Point72 Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Point72 Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $64M | 2.5M | 25.27 |
| 2024-09-30 | $57M | 1.7M | 33.99 |
| 2024-06-30 | $72M | 1.9M | 37.01 |
| 2024-03-31 | $54M | 1.3M | 41.97 |
| 2023-12-31 | $109M | 2.8M | 39.66 |
| 2023-09-30 | $37M | 1.3M | 27.52 |
| 2023-06-30 | $40M | 1.2M | 33.93 |
| 2023-03-31 | $8.3M | 230k | 35.98 |
| 2022-12-31 | $23M | 506k | 44.57 |
| 2022-09-30 | $3.8M | 135k | 28.11 |
| 2021-03-31 | $950k | 46k | 20.61 |